- Active not recruitingPHASE3
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
This study is testing a new medicine called ripretinib against an existing one, sunitinib, for people with advanced GIST. It's for those whose GIST has specific gene changes and has progressed after earlier treatment with imatinib.
For: GISTUnited States · Australia · Brazil - Active not recruitingPHASE3
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
This study compares two treatments, ripretinib and sunitinib, for advanced GIST (a type of cancer) in patients who have already been treated with imatinib. It aims to see which treatment works best.
For: Gastrointestinal Stromal TumorsUnited States · Argentina · Australia